An Innovative Gateway to Deliver Nanosized Atorvastatin by Bio-Flexy Film Approach

1
Kirti Singh
Kirti Singh
2
N. V. Satheesh Madhav
N. V. Satheesh Madhav

Send Message

To: Author

GJMR Volume 18 Issue B5

Article Fingerprint

ReserarchID

PDDTM54306

An Innovative Gateway to Deliver Nanosized Atorvastatin by Bio-Flexy Film Approach Banner
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Atorvastatin is an antihyperlipidemic drug which is widely used to treat hyperlipidemia and lower the cholesterol level in the body, but atorvastatin has low bioavailability due to high intestinal clearance and first-pass metabolism. The main objective of our research work was to develop a formulation to increase the therapeutic efficacy of the drug. A bio-polymer was isolated from a natural edible source Coriandrum sativum and was subjected for screening its filmability and adhesivity. Atorvastatin was nanosized using a novel method and using the bio-polymer and other co-processing agents five bio-flexy films of different ratios (i.e. 1:1, 1:2, 1:3, 1:4, 1:5) were formulated. The isolated bio-polymer was subjected to various analytical parameters. The drug-excipient compatibility study was performed using UV and TLC method. The formulated bio-flexy films were evaluated for various parameters like weight, thickness, content uniformity, surface pH, folding endurance, and in-vitro drug permeation. The formulation AC2 (containing 1:2 bio-polymer) was found to be the best formulation having R 2 value 0.9989 with zero order as best fit model.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

Kirti Singh. 2019. \u201cAn Innovative Gateway to Deliver Nanosized Atorvastatin by Bio-Flexy Film Approach\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 18 (GJMR Volume 18 Issue B5): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-B Classification: NLMC Code: QV 785
Version of record

v1.2

Issue date

January 4, 2019

Language

English

Experiance in AR

The methods for personal identification and authentication are no exception.

Read in 3D

The methods for personal identification and authentication are no exception.

Article Matrices
Total Views: 2734
Total Downloads: 1452
2026 Trends
Research Identity (RIN)
Related Research

Published Article

Atorvastatin is an antihyperlipidemic drug which is widely used to treat hyperlipidemia and lower the cholesterol level in the body, but atorvastatin has low bioavailability due to high intestinal clearance and first-pass metabolism. The main objective of our research work was to develop a formulation to increase the therapeutic efficacy of the drug. A bio-polymer was isolated from a natural edible source Coriandrum sativum and was subjected for screening its filmability and adhesivity. Atorvastatin was nanosized using a novel method and using the bio-polymer and other co-processing agents five bio-flexy films of different ratios (i.e. 1:1, 1:2, 1:3, 1:4, 1:5) were formulated. The isolated bio-polymer was subjected to various analytical parameters. The drug-excipient compatibility study was performed using UV and TLC method. The formulated bio-flexy films were evaluated for various parameters like weight, thickness, content uniformity, surface pH, folding endurance, and in-vitro drug permeation. The formulation AC2 (containing 1:2 bio-polymer) was found to be the best formulation having R 2 value 0.9989 with zero order as best fit model.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]
×

This Page is Under Development

We are currently updating this article page for a better experience.

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

An Innovative Gateway to Deliver Nanosized Atorvastatin by Bio-Flexy Film Approach

Kirti Singh
Kirti Singh
N. V. Satheesh Madhav
N. V. Satheesh Madhav

Research Journals